首页 | 本学科首页   官方微博 | 高级检索  
     


Action mechanism of tachyplesin I and effects of PEGylation
Authors:Yuichi Imura  Yoshiyuki Ogawa  Katsumi Matsuzaki
Affiliation:a Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan
b Graduate School of Biostudies, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan
Abstract:PEGylation of protein and peptide drugs is frequently used to improve in vivo efficacy. We investigated the action mechanism of tachyplesin I, a membrane-acting cyclic antimicrobial peptide from Tachypleus tridentatus and the effects of PEGylation on the mechanism. The PEGylated peptide induced the leakage of calcein from egg yolk l-α-phosphatidylglycerol/egg yolk l-α-phosphatidylcholine large unilamellar vesicles similarly to the parent peptide. Both peptides induced lipid flip-flop coupled to leakage and was translocated into the inner leaflet of the bilayer, indicating that tachyplesin I forms a toroidal pore and that PEGylation did not alter the basic mechanism of membrane permeabilization of the parent peptide. Despite their similar activities against model membranes, the peptides showed very different biological activities. The cytotoxicity of tachyplesin I was greatly reduced by PEGylation, although the antimicrobial activity was significantly weakened. We investigated the enhancement of the permeability of inner membranes induced by the peptides. Our results suggested that outer membranes and peptidoglycan layers play an inhibitory role in the permeation of the PEG moiety. Furthermore, a reduction in DNA binding by PEGylation may also contribute to the weak activity of the PEGylated peptide.
Keywords:AMEM, Alpha modification of Eagle's medium   C6-NBD-PC, 1-palmitoyl-2-[6-[(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino]caproyl]-  smallcaps"  >l-α-phosphatidylcholine   CD, circular dichroism   CFU, colony forming unit   CHO, Chinese Hamster Ovary   DNS-PE, N-(5-dimethylaminonaphthalene-1-sulfonyl)-1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine, triethylammonium salt   FBS, fetal bovine serum   Fmoc, 9-fluorenylmethoxycarbonyl   HPLC, high-performance liquid chromatography   L/P, lipid-to-peptide molar ratio   LUVs, large unilamellar vesicles   MIC, minimal inhibitory concentration   MLVs, multilamellar vesicles   NAPB, 10   mM sodium phosphate/100   mM NaCl, pH 7.4 buffer   ONPG, o-nitrophenyl-β-  smallcaps"  >d-galactoside   PC, egg yolk   smallcaps"  >l-α-phosphatidylcholine   PEG, polyethyleneglycol   PG,   smallcaps"  >l-α-phosphatidyl-  smallcaps"  >dl-glycerol enzymatically converted from PC   Pyrene-PC, 1-hexadecanoyl-2-(1-pyrenehexanoyl)-sn-glycero-3-phosphocholine   SUVs, small unilamellar vesicles   TSB, tryptic soy broth   WST-1, 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号